Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case study
Marion Subklewe, Giulia Magno, Christina Gebhardt, Veit Bücklein, Franziska Szelinski, Héctor Julián Rincón Arévalo, Gerulf Hänel, Thomas Dörner, Gerhard Zugmaier, Michael von Bergwelt‐Baildon, Alla Skapenko, Hendrik Schulze‐Koops
Topics & Concepts
ImmunologyMedicineImmune systemImmune dysregulationT cellBlinatumomabCD19ImmunotherapyCancer researchSystemic Sclerosis and Related DiseasesCAR-T cell therapy researchCutaneous lymphoproliferative disorders research